Renal Cancer - Results from #8360

Current status of pharmacotherapy against metastatic renal cell carcinoma in Japan - Abstract July 17, 2012

Metastatic renal cell carcinoma to the orbit and the ethmoid sinus - Abstract July 17, 2012

Centrally infiltrating renal masses on CT: differentiating intrarenal transitional cell carcinoma from centrally located renal cell carcinoma - Abstract July 16, 2012

Everolimus in metastatic renal cell carcinoma patients intolerant to previous VEGFr-TKI therapy: A RECORD-1 subgroup analysis - Abstract July 13, 2012

Outcome of patients with renal cell carcinoma metastatic to the brain treated with sunitinib without local therapy - Abstract July 13, 2012

Incidence and prognostic significance of second primary cancers in renal cell carcinoma - Abstract July 12, 2012

Duration of targeted therapy for metastatic renal cell carcinoma: A review of current practices - Abstract July 12, 2012

Patterns of interstitial lung disease during everolimus treatment in patients with metastatic renal cell carcinoma - Abstract July 11, 2012

Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinoma - Abstract July 11, 2012

Severe paraneoplastic hypereosinophilia in metastatic renal cell carcinoma - Abstract July 10, 2012

Circulating biomarkers in advanced renal cell carcinoma: Clinical applications - Abstract July 10, 2012

Impact of comorbidity on complications after nephrectomy: Use of the Clavien Classification of Surgical Complications - Abstract July 9, 2012

Embolisation of bone metastases from renal cancer - Abstract July 9, 2012

Randomized phase II trial of sunitinib on an intermittent versus continuous dosing schedule as first-line therapy for advanced renal cell carcinoma - Abstract July 6, 2012

Nephron sparing surgery in von Hippel-Lindau associated renal cell carcinoma; clinicopathological long-term follow-up - Abstract July 6, 2012

Cigarette smoking and renal cell carcinoma risk among black and white Americans: Effect modification by hypertension and obesity - Abstract July 5, 2012

Evaluation of treatment options for patients with advanced renal cell carcinoma: Assessment of appropriateness, using the validated semi-quantitative RAND corporation/University of California, Los Angeles methodology - Abstract July 5, 2012

The effect of sunitinib on primary renal cell carcinoma and facilitation of subsequent surgery - Abstract July 4, 2012

External validation of a nomogram using RENAL nephrometry score to predict high grade renal cell carcinoma - Abstract July 4, 2012

Renal cell carcinoma associated with peritumoral sarcoid-like reaction without intratumoral granuloma - Abstract July 3, 2012

Page 419 of 456